Rockefeller Capital Management’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.62K Buy
1,584
+1,534
+3,068% +$7.38K ﹤0.01% 4155
2025
Q4
$241 Sell
50
-250
-83% -$1.21K ﹤0.01% 4582
2025
Q3
$1.52K Buy
+300
New +$1.32K ﹤0.01% 4129
2023
Q1
Sell
-450
Closed -$1K 2197
2022
Q4
$1K Hold
450
﹤0.01% 3643
2022
Q3
$1K Sell
450
-160
-26% -$822 ﹤0.01% 3672
2022
Q2
$2K Hold
610
﹤0.01% 3752
2022
Q1
$5K Hold
610
﹤0.01% 3317
2021
Q4
$5K Hold
610
﹤0.01% 3244
2021
Q3
$6K Hold
610
﹤0.01% 3081
2021
Q2
$6K Sell
610
-1,150
-65% -$11.4K ﹤0.01% 2957
2021
Q1
$18K Sell
1,760
-240
-12% -$3.34K ﹤0.01% 2320
2020
Q4
$22K Buy
+2,000
New +$20.4K ﹤0.01% 1961

Other funds holding SRTA

Rockefeller Capital Management's SRTA Position: Q1 2026 in Review

Rockefeller Capital Management increased its Strata Critical Medical Inc (SRTA) stake by 3,068% in Q1 2026, buying an estimated $7.38K and bringing the position to 1,584 shares worth $6.62K. The position accounts for ﹤0.01% of the portfolio, ranked #4155.

Rockefeller Capital Management first reported a position in SRTA in Q4 2020 and has held it in 12 quarters since. The position peaked at $22K in Q4 2020. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Rockefeller Capital Management held 1,584 shares of Strata Critical Medical Inc worth $6.62K as of Q1 2026.
  • Rockefeller Capital Management bought 1,534 Strata Critical Medical Inc shares in Q1 2026, an estimated $7.38K.
  • Strata Critical Medical Inc made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4155 holding.
  • Rockefeller Capital Management first reported a position in Strata Critical Medical Inc in Q4 2020 and has held it in 12 quarters since.
  • Rockefeller Capital Management's Strata Critical Medical Inc position peaked at $22K in Q4 2020.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.